Group 1: New Stock Listings - Three new stocks are listed today: Linping Development on the Shanghai Stock Exchange, Dianke Lantian on the Sci-Tech Innovation Board, and Aide Technology on the Beijing Stock Exchange [1][2][5] Group 2: Linping Development - Linping Development is a leading paper manufacturing company in Anhui Province, focusing on the research, production, and sales of corrugated paper and boxboard products [1] - The company achieved revenues of 2.879 billion yuan, 2.800 billion yuan, and 2.485 billion yuan for the years 2022, 2023, and 2024 respectively, with net profits of 154 million yuan, 212 million yuan, and 153 million yuan [1] - For 2025, the company forecasts a revenue growth of 6.23% to 2.87 billion yuan and a net profit increase of 17.76% to 2.12 billion yuan [1] Group 3: Dianke Lantian - Dianke Lantian is a leader in aerospace power systems in China, with products including space solar battery arrays and lithium-ion battery packs, serving national and commercial aerospace sectors [1] - The company has become a major supplier for large satellite constellations, supporting over 700 spacecraft and covering significant national projects [1] - The aerospace power business accounted for 74% of the company's revenue, with a domestic market share exceeding 50% [1] Group 4: Aide Technology - Aide Technology specializes in the research, production, and sales of orthopedic medical devices, focusing on spinal, trauma, and sports medicine products [2][6] - The company reported revenues of 262.1 million yuan, 274.9 million yuan, and 301.7 million yuan for the years 2023, 2024, and 2025 respectively, with net profits of 63.57 million yuan, 67.13 million yuan, and 77.75 million yuan [2] - The company forecasts a revenue growth of 0.35% to 3.85 million yuan for 2025, while net profit is expected to fluctuate between -3.18% to 6.81% [2]

New IPOs This Week - Two new stocks are scheduled for subscription this week: Yisiwei (688816) and Aide Technology (920180) [1][3] - Yisiwei is a leader in automotive manufacturing machine vision equipment and plays a significant role in the localization process of this field in China [1][5] - Aide Technology focuses on the research, production, and sales of orthopedic medical devices, primarily orthopedic consumables [6][7] Company Overview: Yisiwei - Established in 2017, Yisiwei has developed over ten products that are applied across six major manufacturing processes: stamping, welding, painting, assembly, battery, and die-casting [1][5] - The company has achieved a competitive advantage by offering a comprehensive range of products and significantly reducing the costs of machine vision equipment for the domestic automotive industry [5] - Yisiwei has established partnerships with over 80% of domestic passenger car manufacturers [1][5] Company Overview: Aide Technology - Aide Technology has been in the orthopedic medical device industry for over ten years, focusing on clinical needs and developing a comprehensive product matrix covering various orthopedic fields [6][7] - The company initially specialized in spinal minimally invasive intervention and has expanded its offerings to include products for trauma, sports medicine, and wound healing [7] - Aide Technology aims to become a leading provider of comprehensive orthopedic surgical solutions in China [6][7] Market Position and Financials - Yisiwei's revenue scale is below the average of comparable companies, which is projected to be 1.573 billion yuan for 2024, with an average gross margin of 49.11% [5] - Aide Technology's revenue and gross margin are also below the average of its comparable companies, which have an average revenue of 1.166 billion yuan and a gross margin of 64.61% [7]

Group 1: New Stock Offerings - Two new stocks are available for subscription on February 2, including Yisiwei on the Sci-Tech Innovation Board and Aide Technology on the Beijing Stock Exchange [2] - Aide Technology's total issuance, online issuance, and subscription limit rank first among new stocks on the Beijing Stock Exchange since 2026, with a subscription limit of 1.3288 million shares [2][3] - The total issuance of Aide Technology is 29.53 million shares, with 26.58 million shares available for online subscription [4] Group 2: Aide Technology Overview - Aide Technology is a leading company in the domestic medical device sector, focusing on orthopedic consumables, including spinal, trauma, and sports medicine products [4][6] - The company ranks third in the domestic market for spinal vertebral body augmentation systems and sixth for spinal implant medical devices [6] - Aide Technology's revenue for 2022 to 2025 is projected to be 286 million, 262 million, 275 million, and 149 million yuan, respectively, with net profits of approximately 93.28 million, 63.57 million, 67.13 million, and 38.15 million yuan [8][9] Group 3: Yisiwei Overview - Yisiwei is a leading company in the domestic machine vision sector, focusing on the development, production, and sales of machine vision equipment for automotive manufacturing [10][11] - The total issuance of Yisiwei is 25 million shares, with 6 million shares available for online subscription and a subscription limit of 600 shares [11] - Yisiwei's revenue for 2022 to 2025 is projected to be 223 million, 355 million, 392 million, and 125 million yuan, respectively, with net profits of approximately 6.12 million, 61.06 million, 85.64 million, and a loss of 509,910 yuan [13][14]

Group 1 - The Beijing Stock Exchange and Shanghai Stock Exchange will hold meetings on November 21 to review four IPO applications, all of which have been approved [1] - Aide Technology focuses on orthopedic medical devices, including spinal, trauma, and sports medicine products, aiming to become a leading provider in the domestic market [2] - The company has developed multiple core technologies and holds 110 patents, including 45 invention patents, and has received various recognitions as a high-tech enterprise [2][9] Group 2 - The IPO will be sponsored by Debon Securities, with a total share capital of approximately 88.59 million shares, planning to issue up to 29.53 million shares [3] - The major shareholders are Lu Qiang and Huang Meiyu, who together control 79.07% of the company [4] - The company aims to raise 197 million yuan for three major projects, including orthopedic consumables expansion and R&D center construction [6] Group 3 - Financial data shows total assets of approximately 652 million yuan as of June 30, 2025, with a net profit of about 38.22 million yuan for the first half of 2025 [5] - The company has maintained a low debt ratio, with a debt-to-asset ratio of 13.07% as of June 30, 2025 [5] - The company has a strong revenue stream, with reported revenues of 149 million yuan for the first half of 2025 [5] Group 4 - The company has a comprehensive product matrix covering all areas of orthopedics, including spinal, trauma, joint, and sports medicine [8] - Aide Technology emphasizes providing affordable and high-quality orthopedic products, focusing on grassroots medical markets [9] - The company has established a strong brand presence in the minimally invasive spinal treatment sector [9]